Publication | Open Access

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study

OncologyEsophageal CancerEsophageal-gastric Junction AdenocarcinomaMedicineFolinic AcidPathologyAdvanced GastricCancer TreatmentPharmacologyRadiation OncologyCancer Research